Clinical Handbook of Psychotropic Drugs

Clinical Handbook of Psychotropic Drugs

Edited by: Ric M. Procyshyn, Kalyna Z. Bezchlibnyk-Butler, J. Joel Jeffries

Print edition
Print edition
Clinical Handbook of Psychotropic Drugs
ISBN: 9780889375932
24th edition 2021, iv/432 pages + 63 pp. of printable PDF patient information sheets
Due July 2021
ca. €79.95
bookmark
Clinical Handbook of Psychotropic Drugs

The 23rd edition is still available!

Quick and comprehensive information on psychotropic drugs for adults.

  • Accurate and up-to-date
  • Comparison charts help decision-making
  • Icons and full color
  • Available in print and online
  • Downloadable patient info sheets

More about this book

The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

  • Independent, unbiased, up-to-date
  • Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
  • Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
  • Potential interactions and side effects summarized in comparison charts
  • With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
  • Clearly written patient information sheets available for download as printable PDF files

This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.

New in this edition

  • “Neuroscience-based nomenclature – Pharmacological target/Mode of action” column added to Product Availability Tables (in Antidepressants, Antipsychotics)
  • Antidepressants chapter includes new section on GABAA Receptor Positive Modulator (Brexanolone IV injection; trade name Zulresso), also updates to SSRIs use in pregnancy and augmentation strategies
  • Antipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairment
  • Mood stabilisers chapter sections on Lithium and Anticonvulsants have been extensively revised.
  • New formulations and trade names include: Caplyta (lumateperine), Dayvigo (Lemborexant), Perseris (risperidone extended-release subcutaneous injection)
  • Previous praise for the Clinical Handbook

    “This is the new edition [23rd] of a very important book that provides valuable information which otherwise would be scattered among different publications. With the increasing rate of prescription of psychotropic drugs, this volume should be on the desk of every physician. The information is crucial for understanding side effects, vulnerabilities, and interactions of psychotropic drug treatment.”
    Giovanni A. Fava, MD, in Psychotherapy and Psychosomatics, 2019

    “As a psychiatrist who routinely prescribes medications, I find this handbook invaluable. It is the most comprehensive book on this topic that I have come across.”
    Corey Goldstein, MD, Rush University Medical Center

    “A powerhouse of practical information ...Unrivalled in scope ... This outstanding and unique handbook is as rich in useful content as many full textbooks.”
    Barbara Jovaisas, PharmD, in Canadian Pharmacists Journal

    “Comprehensive … clearly organized … an ideal resource for rapid and straight-forward retrieval of essential clinical information ... a ‘must have’ for those who work in mental health care.”
    Marshall Cates, PharmD, in Annals of Pharmacotherapy

    “Should be available at all nursing stations.”
    C. Lindsay DeVane, PharmD, in American Journal of Health Systems Pharmacy

    “The handbook is easy to use, comprehensive in scope, and up to date – a winner!"
    Catherine Chiles, MD, in the Journal of Clinical Psychiatry

Ref-ID: 600593 P-ID: 600593_M

Artikel Hinzugefügt